Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Tyndale

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Pharmacogenetics|November 14, 1997
Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependenceR F Tyndale, K P Droll, E M Sellers
Molecular and Cellular Neurosciences|May 1, 1996
Intercellular calcium waves in neuronsA C Charles, S K Kodali, R F Tyndale
Nature|July 9, 1998
Nicotine metabolism defect reduces smokingM L Pianezza, E M Sellers, R F Tyndale
Pharmacogenetics|April 1, 1997
CYP2D6 phenotype and genotype in a Canadian Native Indian populationM P Nowak, R F Tyndale, E M Sellers
The Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
A major role for CYP2A6 in nicotine C-oxidation by human liver microsomesE S Messina, R F Tyndale, E M Sellers
Clinical Pharmacology and Therapeutics|November 3, 1998
Canadian Native Indians exhibit unique CYP2A6 and CYP2C19 mutant allele frequenciesM P Nowak, E M Sellers, R F Tyndale
NIDA Research Monograph|January 1, 1997
The potential role of the cytochrome P-450 2D6 pharmacogenetic polymorphism in drug abuseE M Sellers, S V Otton, R F Tyndale
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 5, 2002
A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumptionR F Tyndale, M L Pianezza, E M Sellers
Biochemical Pharmacology|October 13, 2001
Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brainK A Schoedel, E M Sellers, R F Tyndale
British Journal of Pharmacology|March 12, 2014
Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeysR T Miller, S Miksys, E Hoffmann, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Pharmacogenetics|November 14, 1997
Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependenceR F Tyndale, K P Droll, E M Sellers
Molecular and Cellular Neurosciences|May 1, 1996
Intercellular calcium waves in neuronsA C Charles, S K Kodali, R F Tyndale
Nature|July 9, 1998
Nicotine metabolism defect reduces smokingM L Pianezza, E M Sellers, R F Tyndale
Pharmacogenetics|April 1, 1997
CYP2D6 phenotype and genotype in a Canadian Native Indian populationM P Nowak, R F Tyndale, E M Sellers
The Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
A major role for CYP2A6 in nicotine C-oxidation by human liver microsomesE S Messina, R F Tyndale, E M Sellers
Clinical Pharmacology and Therapeutics|November 3, 1998
Canadian Native Indians exhibit unique CYP2A6 and CYP2C19 mutant allele frequenciesM P Nowak, E M Sellers, R F Tyndale
NIDA Research Monograph|January 1, 1997
The potential role of the cytochrome P-450 2D6 pharmacogenetic polymorphism in drug abuseE M Sellers, S V Otton, R F Tyndale
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 5, 2002
A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumptionR F Tyndale, M L Pianezza, E M Sellers
Biochemical Pharmacology|October 13, 2001
Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brainK A Schoedel, E M Sellers, R F Tyndale
British Journal of Pharmacology|March 12, 2014
Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeysR T Miller, S Miksys, E Hoffmann, et al.
Pageof 9